Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interleukin 10 receptor alpha subunit (IL10RA) is the ligand-binding component of the interleukin-10 (IL-10) receptor complex. It mediates immunosuppressive signals from IL-10 by inhibiting the synthesis of proinflammatory cytokines, promoting survival of myeloid progenitor cells, and downregulating MHCII and costimulatory molecules on dendritic cells/macrophages. Defects or mutations in IL10RA are linked to early-onset inflammatory bowel disease. It also plays a role in tumor immunity.
Agonism via IL-10 binding, leading to JAK-STAT pathway activation and downstream gene expression changes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 10 Receptor Alpha Subunit.